Welcome!
ALERT * * * Happy Holidays from the iLab Support Team * * *
We are here to support you through the season, with holiday closures varying by region:
We're fully staffed on all other days and ready to assist!
For urgent matters:
Add “Urgent” to your ticket or email subject, or press “1” when prompted on the iLab Support phone and we will prioritize your request first.
Wishing you warmth, rest, and joyful moments this holiday season, wherever you are in the world!
Objective of the Unit: The QMUL Lipid Mediator Unit is a QMUL resource that provides the instrumentation and expertise to investigate endogenous protective mechanisms that may become disregulated in disease with a focus on bioactive lipid mediators (Figure 1).
Overview: The Unit utilizes state of the art Liquid Chromatography Tandem Mass Spectrometry (LC-MS-MS; Figure 2) based techniques to identify and quantify bioactive lipid mediators (LM), their precursors and pathway markers in biological systems. The Unit also utilizes LC-MS-MS based techniques to identify and quantify both known and novel further metabolites for each of the bioactive mediators. Together these provide an insight into the resolution status of the biological system(s) being investigated (e.g. cell incubations, organs, tissues etc), protective pathways that become dysregulated during disease as well as potential novel therapeutic leads.
| Name | Role | Phone | Location | |
|---|---|---|---|---|
| Dr. Jesmond Dalli |
Director
|
44 (0) 207 882 5654
|
j.dalli@qmul.ac.uk
|
William Harvey Research Institute
|
